CD44 binding through the hemopexin-like domain is critical for its shedding by membrane-type 1 matrix metalloproteinase

Oncogene

Volumn 24, Issue 5, 2005, Pages 859-868

  Suenaga, Naoko ^a   Mori, Hidetoshi ^a,b   Itoh, Yoshifumi ^a,c   Seiki, Motoharu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

CD44; Hemopexin like domain; MT MMP

Indexed keywords

HEMOPEXIN; HERMES ANTIGEN; HYALURONIC ACID; MATRIX METALLOPROTEINASE 14;

ARTICLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; ENZYME ACTIVE SITE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN;

ANTIGENS, CD44; BINDING SITES; BIOTINYLATION; CELL LINE, TUMOR; CELL MOVEMENT; FIBROSARCOMA; HEMOPEXIN; HUMANS; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; RECOMBINANT FUSION PROTEINS; TRANSFECTION;

EID: 13444273084     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208258     Document Type: Article

References (27)

1. Abecassis I, Olofsson B, Schmid M, Zalcman G and Karniguian A. (2003). Exp. Cell Res., 291, 363-376.
2. Bourguignon LY, Gunja-Smith Z, Iida N, Zhu HB, Young LJ, Muller WJ and Cardiff RD. (1998). J. Cell. Physiol., 176, 206-215.
3. Egeblad M and Werb Z. (2002). Nat. Rev. Cancer, 2, 161-174.
4. Goebeler M, Kaufmann D, Brocker EB and Klein CE. (1996). J. Cell Sci., 109, 1957-1964.
5. Ha HY, Moon HB, Nam MS, Lee JW, Ryoo ZY, Lee TH, Lee KK, So BJ, Sato H, Seiki M and Yu DY. (2001). Cancer Res., 61, 984-990.
6. Ho SN, Hunt HD, Horton RM, Pullen JK and Pease LR. (1989). Gene, 77, 51-59.
7. Hotary KB, Allen ED, Brooks PC, Datta NS, Long MW and Weiss SJ. (2003). Cell, 114, 33-45.
8. Itoh Y, Kajita M, Kinoh H, Mori H, Okada A and Seiki M. (1999). J. Biol. Chem., 274, 34260-34266.
9. Itoh Y, Takamura A, Ito N, Maru Y, Sato H, Suenaga N, Aoki T and Seiki M. (2001). EMBO J., 20, 4782-4793.
10. Kajita M, Itoh Y, Chiba T, Mori H, Okada A, Kinoh H and Seiki M. (2001). J. Cell Biol., 153, 893-904.
11. Kojima S, Itoh Y, Matsumoto S, Masuho Y and Seiki M. (2000). FEBS Lett., 480, 142-146.
12. Massova I, Kotra LP, Fridman R and Mobashery S. (1998). FASEB J., 12, 1075-1095.
13. Mori H, Tomari T, Koshikawa N, Kajita M, Itoh Y, Sato H, Tojo H, Yana I and Seiki M. (2002). EMBO J., 21, 3949-3959.
14. Murai T, Miyazaki Y, Nishinakamura H, Sugahara KN, Miyauchi T, Sako Y, Yanagida T and Miyasaka M. (2003). J. Biol. Chem., 279, 4541-4550.
15. Nagano O, Murakami D, Hartmann D, De Strooper B, Saftig P, Iwatsubo T, Nakajima M, Shinohara M and Saya H. (2004). J. Cell Biol., 165, 893-902.
16. Nakamura H, Suenaga N, Taniwaki K, Matsuki H, Yonezawa K, Fujii M, Okada Y and Seiki M. (2004). Cancer Res., 64, 876-882.
17. Naot D, Sionov RV and Ish-Shalom D. (1997). Adv. Cancer Res., 71, 241-319.
18. Okamoto I, Tsuiki H, Kenyon LC, Godwin AK, Emlet DR, Holgado-Madruga M, Lanham IS, Joynes CJ, Vo KT, Guha A, Matsumoto M, Ushio Y, Saya H and Wong AJ. (2002). Am. J. Pathol., 160, 441-447.
19. Ponta H, Sherman L and Herrlich PA. (2003). Nat. Rev. Mol. Cell Biol., 4, 33-45.
20. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E and Seiki M. (1994). Nature, 370, 61-65.
21. Seiki M, Koshikawa N and Yana I. (2003). Cancer Metast. Rev., 22, 129-143.
22. Tsunezuka Y, Kinoh H, Takino T, Watanabe Y, Okada Y, Shinagawa A, Sato H and Seiki M. (1996). Cancer Res., 56, 5678-5683.
23. Ueda J, Kajita M, Suenaga N, Fujii K and Seiki M. (2003). Oncogene, 22, 8716-8722.
24. Vivinus-Nebot M, Rousselle P, Breittmayer JP, Cenciarini C, Berrih-Aknin S, Spong S, Nokelainen P, Cottrez F, Marinkovich MP and Bernard A. (2004). J. Immunol., 172, 1397-1406.
25. Yu Q and Stamenkovic I. (1999). Genes Dev., 13, 35-48.
26. Yu Q and Stamenkovic I. (2000). Genes Dev., 14, 163-176.
27. Yu WH, Woessner Jr JF, McNeish JD and Stamenkovic I. (2002). Genes Dev., 16, 307-323.